|
|
US 7,456,169 B2 |
|
| Heterocyclic kinase inhibitors |
| Lisa A. Hasvold, Grayslake, Ill. (US); Laura Hexamer, Gurnee, Ill. (US); Gaoquan Li, Madison, Wis. (US); Nan-Horng Lin, Vernon Hills, Ill. (US); Hing Sham, South San Francisco, Calif. (US); Thomas J. Sowin, Wadsworth, Ill. (US); Gerard M. Sullivan, Labe Villa, Ill. (US); Le Wang, Mundelein, Ill. (US); and Ping Xia, St. Louis, Mo. (US) |
| Assigned to Abbott Laboratories Inc., Abbott Park, Ill. (US) |
| Filed on Aug. 23, 2006, as Appl. No. 11/466,638. |
| Application 11/466638 is a continuation in part of application No. 10/785120, filed on Feb. 25, 2004, abandoned. |
| Claims priority of provisional application 60/450476, filed on Feb. 27, 2003. |
| Prior Publication US 2007/0254867 A1, Nov. 01, 2007 |
| Int. Cl. C07D 413/00 (2006.01); A61K 31/5513 (2006.01)
|